Videos
More news
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss a new study showing people taking Ozempic and Wegovy may be at an increased risk of developing an eye condition that can cause irreversible vision loss.
Authors of a new study say additional research is needed to determine causality between semaglutide and a condition called NAION
Patients using Novo Nordisk's wildly popular weigh-loss drug Wegovy and its similar medicines for type 2 diabetes may be at increased risk for a sight-threatening eye condition, according to data from a study published on Wednesday.
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.
Those who take Ozempic or Wegovy may have an increased risk of developing a rare form of blindness, though future research is needed to make a final determination, researchers in a new study said.
Researchers from Massachusetts General Hospital found that patients prescribed either Ozempic or Wegovy had an elevated risk of developing NAION.
Ron Hoon and Syleste Rodrigues discuss the latest headlines, including whether weight loss drugs can have an effect on your eyesight.
Find fireworks-worthy deals on everything from sandals and dresses to designer totes — save up to 60%. Automotive research firm J.D. Power’s highly watched initial quality study is out — and it appears EVs are giving consumers big headaches.
A new study shows those who use semaglutide prescriptions like Ozempic and Wegovy face increased risk of a condition that can lead to blindness.
Being prescribed semaglutide for diabetes or weight management is associated with an increased risk, up to seven times, of developing a relatively rare form of untreatable blindness, sometimes referred to as an 'eye stroke,
The study, published July 3 in JAMA Ophthalmology, found patients taking Ozempic and Wegovy were more likely to develop non-arteritic anterior ischemic optic neuropathy, known as NAION, a condition that restricts blood flow to the optic nerve and causes sudden vision loss.